Allied Market Research


Embolotherapy Market

Embolotherapy Market Size, Share, Competitive Landscape and Trend Analysis Report by Product, by Procedure, by Disease Indication : Global Report opportunity Analysis and Industry Forecast, 2023-2033

LS : Diagnostics and Biotech

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Embolotherapy is defined as the blockage of arteries with an object (as a balloon catheter inserted) to control or prevent untreatable hemorrhage. This method is used to control bleeding and reduce tumors. It is an endovascular treatment that aims toward obstructing abnormal blood vessels in order to control bleeding. Embolotherapy plays main role in the management of pelvic tract hemorrhage, postpartum setting and in the treatment of cervical uprooted pregnancy. 

This therapy has proven helpful for management of iatrogenic solid organ, vascular injuries and non-operative management of organ trauma which include liver, spleen and kidneys. Embolotherapy is used for improvement of enlarged uterine fibroids, presurgical devascularization of tissues and organs and obliteration of duodenal varices. This needs selection of an embolization agent with desired permanence of vascular occlusion.

COVID-19 Scenario analysis:

Coronavirus disease 2019 (COVID-19) has created an economic crisis along with a health care crisis. COVID-19 pandemic has stretched healthcare system worldwide, developed countries are expected to cause economic recession. The COVID-19 pandemic has an adverse impact on the healthcare system, resulting in 50% to 70% drop in revenue from March. Many small hospitals, clinics and nursing homes, have been forced to shut their operations. As a result of social distancing and localized curfews have resulted in delayed elective surgical procedures. In addition, visa cancellations have led to a hiatus in medical tourism and can negatively impact the healthcare services market growth.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The embolotherapy market is used on larger platform and also plays an important role in medication. The treatment helps to control bleeding and reduction in tumors. Increasing prevalence of chronic diseases is driving the market growth. Increase in liver cancer cases and hepatocellular cancer and rise in the number of patients undergoing treatment are expected to drive the embolotherapy market growth.

Lack of skilled radiologists for the treatment of embolotherapy would restrain the growth of embolotherapy market. Further, there is rise in the cases of tumor, infertility in males and impotence globally, and embolotherapy is handling the patients suffering from these diseases. It is found that every year many people are treated with liver cancer and most of them die due to the failure of the treatment. And the percentages of people who recover are very less as compared to suffering patients. These factors would drive the growth of the embolotherapy market.

Increase in the consumption of junk foods and negligence toward regular exercise causes the increase in the cases of rising levels of stress and obesity in today’s generation. These are the main drivers of the embolotherapy market. The increasing cases of several chronic diseases like cancer, strokes, and their growing harmful effects on the population will create more opportunities for growth in the embolotherapy market.

Key benefits of the report:

  • This study presents the analytical depiction of the industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global embolotherapy market share.
  • The current market is quantitatively analyzed to highlight the global embolotherapy market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Embolotherapy Market research report:

  • What are the leading market players active in the embolotherapy market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What can be the challenges for global embolotherapy market in future?
  • What are the projections for the future that would help in taking further strategic steps?

Embolotherapy Market Report Highlights

Aspects Details
By Product
  • Embolic Coils
    • Detachable Coils
    • Pushable Coils
  • Embolic Agents
    • Liquid Embolic Agents
    • Microspheres
  • Detachable Balloon
  • Embolic Plug System
  • Support Devices
By Procedure
  • Transcatheter Arterial Embolization (TAE)
  • Transcatheter Arterial Radioembolization (TARE)
  • Transarterial Chemoembolization (TACE)
    • cTACE
    • DEB-TACE
  • Transarterial Radioembolization (TARE)
By Disease Indication
  • Oncology
  • Peripheral Vascular Disease
  • Neurological Diseases
  • Urological
  • Nephrological Disorders
  • Gastrointestinal Disorders
  • Others
By Region
  • Europe  (FRANCE, GERMANY, ITALY, SPAIN, UNITED KINGDOM, Russia, Rest of Europe)
  • LAMEA  (Brazil, South Africa,, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players

AstraZeneca, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., Guerbet, Sirtex Medical Limited, Imbiotechnologies Ltd., Stryker Corporation, Penumbra, Inc., Medtronic, Kaneka Corporation, Simbionix USA Corporation, Merit Medical Systems, Inc., Terumo Corporation, Cook Medical, Johnson And Johnson

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Embolotherapy Market

Global Report opportunity Analysis and Industry Forecast, 2023-2033